Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors

Clinical trial NCT03647163 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03647163
Sponsor: Vyriad, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Non Small Cell Lung Cancer Neuroendocrine Carcinoma Renal Cell Carcinoma (RCC)

Start date: 2019-04-09
Primary completion: 2025-07-31
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.